Amylyx Pharmaceuticals Inc (AMLX)
Cash & Short-Term Investments
$250.76M
Quarterly · Period ending: · USD
AMLX Cash & Short-Term Investments
Latest reported$250.76Mperiod ending
Latest reported$250.76Mperiod ending
AMLX Quarterly Cash & Short-Term Investments ($125.70M → $250.76M)
Quarterly Cash & Short-Term Investments
High-resolution chart · PNG
AMLX cash & short-term investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Short-Term Investments (USD) |
|---|---|
| 250,760,000 | |
| 279,768,000 | |
| 316,979,000 | |
| 343,990,000 | |
| 180,826,000 | |
| 204,068,000 | |
| 176,501,000 | |
| 234,395,000 | |
| 309,812,000 | |
| 373,293,000 | |
| 371,362,000 | |
| 355,045,000 | |
| 357,276,000 | |
| 345,674,000 | |
| 346,945,000 | |
| 162,593,000 | |
| 206,681,000 | |
| 255,205,000 | |
| 96,118,000 | |
| 125,702,000 |